Cargando…
Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer
Gastric cancer (GC) is one of the most frequently diagnosed malignancies in East Asia, particularly in China, and remains the second leading cause of cancer-associated mortality worldwide. However, no effective plasma biomarkers have been identified for the diagnosis of patients with GC. The aim of...
Autores principales: | ZHANG, XIE, ZHANG, XUESONG, SUN, BEILEI, LU, HONGNA, WANG, DANPING, YUAN, XIAOGANG, HUANG, ZHIGANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156173/ https://www.ncbi.nlm.nih.gov/pubmed/25202403 http://dx.doi.org/10.3892/ol.2014.2410 |
Ejemplares similares
-
DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA
por: LU, HONGNA, et al.
Publicado: (2014) -
Plasma Methylated RNF180 for Noninvasive Diagnosis of Gastric Cancer
por: Zhao, Luyao, et al.
Publicado: (2022) -
Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancer
por: Nie, Yongzhan, et al.
Publicado: (2023) -
Diagnostic value of plasma RNF180 gene methylation for gastric cancer: A systematic review and meta-analysis
por: Wang, Tongxin, et al.
Publicado: (2023) -
Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer
por: Deng, Jingyu, et al.
Publicado: (2014)